- Home
- KMDA vs VNDA Comparison
KMDA vs VNDA Comparison
Compare KMDA & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- VNDA
- Stock Information
- Founded
- KMDA 1990
- VNDA 2002
- Country
- KMDA Israel
- VNDA United States
- Employees
- KMDA N/A
- VNDA N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- KMDA Health Care
- VNDA Health Care
- Exchange
- KMDA Nasdaq
- VNDA Nasdaq
- Market Cap
- KMDA N/A
- VNDA 270.2M
- IPO Year
- KMDA N/A
- VNDA 2006
- Fundamental
- Price
- KMDA $5.30
- VNDA $4.74
- Analyst Decision
- KMDA Strong Buy
- VNDA Buy
- Analyst Count
- KMDA 2
- VNDA 1
- Target Price
- KMDA $14.50
- VNDA $13.00
- AVG Volume (30 Days)
- KMDA 18.6K
- VNDA 692.7K
- Earning Date
- KMDA 11-11-2024
- VNDA 11-06-2024
- Dividend Yield
- KMDA N/A
- VNDA N/A
- EPS Growth
- KMDA 230.67
- VNDA N/A
- EPS
- KMDA 0.25
- VNDA N/A
- Revenue
- KMDA $154,574,000.00
- VNDA $182,022,000.00
- Revenue This Year
- KMDA $14.85
- VNDA $6.70
- Revenue Next Year
- KMDA $7.64
- VNDA $51.03
- P/E Ratio
- KMDA $20.08
- VNDA N/A
- Revenue Growth
- KMDA 6.01
- VNDA N/A
- 52 Week Low
- KMDA $4.08
- VNDA $3.30
- 52 Week High
- KMDA $6.53
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- KMDA 49.09
- VNDA 48.91
- Support Level
- KMDA $5.18
- VNDA $4.68
- Resistance Level
- KMDA $5.33
- VNDA $4.98
- Average True Range (ATR)
- KMDA 0.08
- VNDA 0.17
- MACD
- KMDA 0.01
- VNDA 0.05
- Stochastic Oscillator
- KMDA 54.17
- VNDA 40.53
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.